Frequently Asked Questions
The market is segmented based on Segmentation, By Pathogens (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), Treatment (Medical Treatment, Surgery), End User (Hospital, Clinics, Ambulatory Centers, Others) – Industry Trends and Forecast to 2031.
.
The Global Yeast Infection Market size was valued at USD 4.37 USD Billion in 2023.
The Global Yeast Infection Market is projected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Scynexis , Merck & Co. , Bayer AG, Astellas Pharma , Thermo Fisher Scientific , Novartis AG, Abbott, Catalent , bioMérieux, Pfizer , AbbVie , ALLERGAN, Jubilant Pharmova Limited, Sanofi, AstraZeneca, Bruker, Brundavan Laboratories , Curia Global , Corden Pharma .
The market report covers data from the U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.
